Treatment with drug combinations has strong effect in inhibiting cell proliferation and increasing cell apoptosis to block cell survival kinase (Akt) and abolish HIF-2 expression in AML, TSC2+/− and TSC−/− cells and in TSC2+/− mouse model. The gene discussed is TSC1; the disease is acute myeloid leukemia.